It is not a bottleneck at the FDA that is to blame. Medical research is simply not producing the breakthroughs needed for breast cancer. And we should not let a reduction of safety and efficacy standards replace our demand for safer and more effective treatments.
Thanks to our failed experiment with alcohol prohibition, we know that it's impossible to keep people away from intoxicants, legal or otherwise. The difference is in how we treat those who favor certain substances over others.